STANDARDIZING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) OR IMMUNE EFFECTOR CELL (IEC) THERAPY ADMISSION

被引：0
|
作者：
Graham, Shawnette
机构：
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P34
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nutritional status of patients undergoing Chimeric Antigen Receptor T-Cell (CAR-T) therapy; a feasibility study
    Carty, Danika
    Ismail, Hilmy
    Traer, Emily
    Riedel, Bernhard
    O'Leary, Nicole
    Harrison, Simon
    Crowe, Jessica
    Kotowicz, Erika
    Edbrooke, Lara
    Ftanou, Maria
    Laing, Erin
    Loeliger, Jenelle
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 174 - 174
  • [22] EEG Findings in Chimeric Antigen Receptor T-Cell (CAR-T) Related Encephalopathy Syndrome
    Satyanarayan, Sammita
    Markert, Matthew
    Hovsepian, Dominic
    Post, David
    Muffly, Lori
    Miklos, David
    Thomas, Reena
    Scott, Brian
    NEUROLOGY, 2019, 92 (15)
  • [23] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [24] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [25] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Giulia Bonaldo
    Nicola Montanaro
    Domenico AlbertoVaccheri
    European Journal of Clinical Pharmacology, 2021, 77 : 1225 - 1234
  • [26] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1225 - 1234
  • [27] Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies
    Abbasi, Samane
    Totmaj, Milad Asghari
    Abbasi, Masoumeh
    Hajazimian, Saba
    Goleij, Pouya
    Behroozi, Javad
    Shademan, Behrouz
    Isazadeh, Alireza
    Baradaran, Behzad
    CANCER MEDICINE, 2023, 12 (07): : 7844 - 7858
  • [28] Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
    Kandra, Prameela
    Nandigama, Rajender
    Eul, Bastian
    Huber, Magdalena
    Kobold, Sebastian
    Seeger, Werner
    Grimminger, Friedrich
    Savai, Rajkumar
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China’s responses to address secondary cancer risks of CAR-T therapy
    Ruirong Tan
    Rui Li
    Meng-Yuan Dai
    Miao Liu
    Junning Zhao
    Journal of Hematology & Oncology, 17 (1)
  • [30] Predictors of Failures following Chimeric Antigen Receptor T-cell (CAR T) Therapy
    Figura, N.
    Jain, M.
    Sim, A.
    Dean, E.
    Balagurunathan, Y.
    Chavez, J.
    Shah, B.
    Khimani, F.
    Lazaryan, A.
    Davila, M.
    Liu, H.
    Kim, S.
    Locke, F.
    Robinson, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S311 - S312
12345